Vanguard Personalized Indexing Management
MRNA icon

Vanguard Personalized Indexing Management’s Moderna MRNA Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.06M Buy
43,679
+218
+0.5% +$11.3K 0.03% 495
2026
Q1 		$2.21M Buy
43,461
+5,493
+14% +$256K 0.02% 565
2025
Q4 		$1.12M Sell
37,968
-10,980
-22% -$298K 0.01% 857
2025
Q3 		$1.26M Sell
48,948
-4,155
-8% -$116K 0.01% 788
2025
Q2 		$1.47M Buy
53,103
+11,609
+28% +$306K 0.02% 689
2025
Q1 		$1.18M Buy
41,494
+10,547
+34% +$374K 0.02% 704
2024
Q4 		$1.29M Buy
30,947
+7,398
+31% +$354K 0.02% 660
2024
Q3 		$1.57M Sell
23,549
-6,955
-23% -$639K 0.03% 558
2024
Q2 		$3.62M Buy
30,504
+6,339
+26% +$802K 0.07% 248
2024
Q1 		$2.58M Buy
24,165
+8,023
+50% +$809K 0.06% 319
2023
Q4 		$1.61M Buy
16,142
+1,820
+13% +$153K 0.04% 428
2023
Q3 		$1.48M Sell
14,322
-1,575
-10% -$176K 0.04% 398
2023
Q2 		$1.93M Sell
15,897
-780
-5% -$104K 0.06% 323
2023
Q1 		$2.56M Sell
16,677
-1,424
-8% -$235K 0.09% 226
2022
Q4 		$3.25M Buy
18,101
+1,683
+10% +$275K 0.13% 146
2022
Q3 		$1.94M Sell
16,418
-1,028
-6% -$156K 0.09% 236
2022
Q2 		$2.49M Buy
17,446
+3,369
+24% +$482K 0.12% 168
2022
Q1 		$2.42M Buy
14,077
+3,714
+36% +$625K 0.12% 159
2021
Q4 		$2.63M Buy
10,363
+2,037
+24% +$596K 0.16% 111
2021
Q3 		$3.2M Buy
8,326
+810
+11% +$299K 0.29% 57
2021
Q2 		$1.77M Buy
7,516
+2,846
+61% +$509K 0.18% 112
2021
Q1 		$612K Buy
4,670
+1,364
+41% +$198K 0.09% 260
2020
Q4 		$345K Buy
+3,306
New +$334K 0.08% 316

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Vanguard Personalized Indexing Management's MRNA Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Moderna (MRNA) stake by 0.5% in Q2 2026, buying an estimated $11.3K and bringing the position to 43,679 shares worth $3.06M. The position accounts for 0.03% of the portfolio, ranked #495.

Vanguard Personalized Indexing Management first reported a position in MRNA in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.62M in Q2 2024. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Vanguard Personalized Indexing Management held 43,679 shares of Moderna worth $3.06M as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 218 Moderna shares in Q2 2026, an estimated $11.3K.
  • Moderna made up 0.03% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #495 holding.
  • Vanguard Personalized Indexing Management first reported a position in Moderna in Q4 2020 and has held it in 23 quarters since.
  • Vanguard Personalized Indexing Management's Moderna position peaked at $3.62M in Q2 2024.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.